Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 1.278
Filtrer
1.
Commun Biol ; 7(1): 1090, 2024 Sep 05.
Article de Anglais | MEDLINE | ID: mdl-39237613

RÉSUMÉ

T cell immunoglobulin and mucin-containing molecule 3 (TIM-3) exhibits unique, cell type- and context-dependent characteristics and functions. Here, we report that TIM-3 on myeloid cells plays essential roles in modulating lung inflammation. We found that myeloid cell-specific TIM-3 knock-in (FSF-TIM3/LysM-Cre+) mice have lower body weight and shorter lifespan than WT mice. Intriguingly, the lungs of FSF-TIM3/LysM-Cre+ mice display excessive inflammation and features of disease-associated pathology. We further revealed that galectin-3 levels are notably elevated in TIM-3-overexpressing lung-derived myeloid cells. Furthermore, both TIM-3 blockade and GB1107, a galectin-3 inhibitor, ameliorated lung inflammation in FSF-TIM3/LysM-Cre+/- mice. Using an LPS-induced lung inflammation model with myeloid cell-specific TIM-3 knock-out mice, we demonstrated the association of TIM-3 with both lung inflammation and galectin-3. Collectively, our findings suggest that myeloid TIM-3 is an important regulator in the lungs and that modulation of TIM-3 and galectin-3 could offer therapeutic benefits for inflammation-associated lung diseases.


Sujet(s)
Galectine -3 , Récepteur cellulaire-2 du virus de l'hépatite A , Cellules myéloïdes , Pneumopathie infectieuse , Animaux , Récepteur cellulaire-2 du virus de l'hépatite A/métabolisme , Récepteur cellulaire-2 du virus de l'hépatite A/génétique , Galectine -3/métabolisme , Galectine -3/génétique , Cellules myéloïdes/métabolisme , Souris , Pneumopathie infectieuse/métabolisme , Pneumopathie infectieuse/anatomopathologie , Pneumopathie infectieuse/génétique , Souris knockout , Souris de lignée C57BL , Galectines/métabolisme , Galectines/génétique , Poumon/anatomopathologie , Poumon/métabolisme
2.
Toxics ; 12(9)2024 Aug 28.
Article de Anglais | MEDLINE | ID: mdl-39330561

RÉSUMÉ

In this study, we developed and validated a multiresidue analytical method for the simultaneous detection of 24 pesticides in fishery products. Using the EN15662 extraction method and C18 as the adsorbent for purification, the validation results complied with Codex guidelines, achieving recovery rates between 70% and 120% and relative standard deviation values (%RSD) within 20%, indicating excellent performance. The limit of detection ranged from 0.25 to 0.8 ng/kg, and the limit of quantification was between 3 and 10 ng/g, providing sufficient sensitivity to comply with future regulatory standards. The calibration curves for all 24 pesticides exhibited great linearity (R2 > 0.98), also satisfying the Codex requirements. The matrix effect was less than 30% for some pesticides-within ±20%-indicating minimal interference from impurities. An analysis of 300 fishery samples from nine regions across South Korea detected lufenuron at 10 ng/g in eels; however, the risk assessment was below 0.19%, posing no significant hazard to public health. This newly developed analytical method proved effective for the multi-analysis of pesticide residues in fishery products, offering rapid and reliable monitoring of the import and export safety of fishery products.

3.
Am J Vet Res ; : 1-8, 2024 Sep 09.
Article de Anglais | MEDLINE | ID: mdl-39250933

RÉSUMÉ

OBJECTIVE: To explain the relationship between cartilage erosion and medial patellar luxation (MPL) and to identify risk factors in dogs. METHODS: A retrospective review was conducted on 90 dogs (103 stifles) surgically treated for MPL between January 2006 and March 2024. Data collected included signalment, side of operated stifle, patellar luxation grade, symptom duration, and lameness score. Cartilage erosion was evaluated for extent and location on the patella and femoral trochlea. Statistical analyses were conducted to identify risk factors. RESULTS: The prevalence of cartilage erosion of the patella and femoral trochlea was 47.6% (49/103) and 54.4% (56/103), respectively, increasing with a higher grade of patellar luxation. Lesions were most prevalent in the distolateral patella and proximomedial trochlea, with generalized lesions more prevalent in grade IV. The extent of both lesions was significantly associated with age, patellar luxation grade, and symptom duration, while body weight significantly correlated only with the cartilage erosion of the patella. No significant correlation was observed with sex, side of operated stifle, or lameness score. CONCLUSIONS: Many patients with MPL exhibited cartilage erosion in the patellofemoral joint, likely due to biomechanical mechanisms. Surgery can be indicated for patients with MPL, as it may prevent cartilage erosion while improving patellofemoral alignment and gait. When selecting surgical candidates, it is important to consider risk factors, such as patellar luxation grade, body weight, age, and symptom duration. CLINICAL RELEVANCE: Early surgical treatment is recommended, especially for dogs with higher body weight and higher grade of MPL, to prevent cartilage erosion and secondary osteoarthritis.

4.
J Med Chem ; 67(19): 17866-17892, 2024 Oct 10.
Article de Anglais | MEDLINE | ID: mdl-39323296

RÉSUMÉ

Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease of the central nervous system (CNS), which leads to demyelination, axonal loss, and neurodegeneration. Increased oxidative stress and neurodegeneration have been implicated in all stages of MS, making neuroprotective therapeutics a promising strategy for its treatment. We previously have reported vinyl sulfones with antioxidative and anti-inflammatory properties that activate nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that induces the expression of cytoprotective genes against oxidative stress. In this study, we synthesized vinyl sulfoximine derivatives by modifying the core structure and determined therapeutic potential as Nrf2 activators. Among them, 10v effectively activated Nrf2 (EC50 = 83.5 nM) and exhibited favorable drug-like properties. 10v successfully induced expression of Nrf2-dependent antioxidant enzymes and suppressed lipopolysaccharide (LPS)-induced inflammatory responses in BV-2 microglial cells. We also confirmed that 10v effectively reversed disease progression and attenuated demyelination in an experimental autoimmune encephalitis (EAE) mouse model of MS.


Sujet(s)
Encéphalomyélite auto-immune expérimentale , Sclérose en plaques , Facteur-2 apparenté à NF-E2 , Facteur-2 apparenté à NF-E2/métabolisme , Facteur-2 apparenté à NF-E2/agonistes , Animaux , Sclérose en plaques/traitement médicamenteux , Encéphalomyélite auto-immune expérimentale/traitement médicamenteux , Souris , Humains , Souris de lignée C57BL , Relation structure-activité , Lignée cellulaire , Sulfones/pharmacologie , Sulfones/synthèse chimique , Sulfones/composition chimique , Sulfones/usage thérapeutique , Découverte de médicament , Femelle , Lipopolysaccharides/pharmacologie , Antioxydants/pharmacologie , Antioxydants/composition chimique , Antioxydants/synthèse chimique , Antioxydants/usage thérapeutique , Composés vinyliques/pharmacologie , Composés vinyliques/composition chimique , Composés vinyliques/synthèse chimique , Composés vinyliques/usage thérapeutique , Microglie/effets des médicaments et des substances chimiques , Microglie/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Imines/composition chimique , Imines/pharmacologie , Imines/usage thérapeutique , Imines/synthèse chimique
5.
Cancer Res ; 2024 Aug 29.
Article de Anglais | MEDLINE | ID: mdl-39207402

RÉSUMÉ

Galectin-9 is a multifaceted regulator of various pathophysiological processes that exerts positive or negative effects in a context-dependent manner. Here, we elucidated the distinctive functional properties of galectin-9 on myeloid cells within the brain tumor microenvironment. Galectin-9-expressing cells were abundant at the hypoxic tumor edge in the tumor-bearing ipsilateral hemisphere compared to the contralateral hemisphere in an intracranial mouse brain tumor model. Galectin-9 was highly expressed in microglia and macrophages in tumor-infiltrating cells. In primary glia, both the expression and secretion of galectin-9 were influenced by tumors. Analysis of a human glioblastoma bulk RNA-sequencing dataset and a single-cell RNA-sequencing dataset from a murine glioma model revealed a correlation between galectin-9 expression and glial cell activation. Notably, the galectin-9high microglial subset was functionally distinct from the galectin-9neg/low subset in the brain tumor microenvironment. Galectin-9high microglia exhibited properties of inflammatory activation and higher rates of cell death, whereas galectin-9neg/low microglia displayed a superior phagocytic ability against brain tumor cells. Blockade of galectin-9 suppressed tumor growth and altered the activity of glial and T cells in a mouse glioma model. Additionally, glial galectin-9 expression was regulated by Hif-2α in the hypoxic brain tumor microenvironment. Myeloid-specific Hif-2α deficiency led to attenuated tumor progression. Together, these findings reveal that galectin-9 on myeloid cells is an immunoregulator and putative therapeutic target in brain tumors.

6.
bioRxiv ; 2024 Aug 06.
Article de Anglais | MEDLINE | ID: mdl-39149236

RÉSUMÉ

The eukaryotic serine/threonine protein phosphatase PP2A is a heterotrimeric enzyme composed of a scaffold A subunit, a regulatory B subunit, and a catalytic C subunit. Of the four known B subunits, the B"' subunit (known as striatin) interacts with the multi-protein striatin-interacting phosphatase and kinase (STRIPAK) complex. Orthologs of STRIPAK components were identified in C. neoformans, namely PP2AA/Tpd3, PP2AC/Pph22, PP2AB"'/Far8, STRIP/Far11, SLMAP/Far9, and Mob3. Structural modeling, protein domain analysis, and detected protein-protein interactions suggest C. neoformans STRIPAK is assembled similarly to the human and fungal orthologs. Here, STRIPAK components Pph22, Far8, and Mob3 were functionally characterized. Whole-genome sequencing revealed that mutations in STRIPAK complex subunits lead to increased segmental and chromosomal aneuploidy, suggesting STRIPAK functions in maintaining genome stability. We demonstrate that PPH22 is a haploinsufficient gene: heterozygous PPH22/pph22Δ mutant diploid strains exhibit defects in hyphal growth and sporulation and have a significant fitness disadvantage when grown in competition against a wild-type diploid. Deletion mutants pph22Δ, far8Δ, and mob3Δ exhibit defects in mating and sexual differentiation, including impaired hyphae, basidia, and basidiospore production. Loss of either PPH22 or FAR8 leads to growth defects at 30°C, severely reduced growth at elevated temperature, abnormal cell morphology, and impaired virulence. The pph22Δ and far8Δ mutants are also unable to grow in the presence of the calcineurin inhibitors cyclosporine A or FK506, and thus these mutations are synthetically lethal with loss of calcineurin activity. Conversely, mob3Δ mutants display increased thermotolerance, capsule production, and melanization, and are hypervirulent in a murine infection model. Taken together, these findings reveal that the C. neoformans STRIPAK complex plays an important role in genome stability, vegetative growth, sexual development, and virulence in this prominent human fungal pathogen.

7.
PLoS One ; 19(8): e0301562, 2024.
Article de Anglais | MEDLINE | ID: mdl-39190696

RÉSUMÉ

Single-cell RNA sequencing (scRNA-seq) has emerged as a versatile tool in biology, enabling comprehensive genomic-level characterization of individual cells. Currently, most scRNA-seq methods generate barcoded cDNAs by capturing the polyA tails of mRNAs, which exclude many non-coding RNAs (ncRNAs), especially those transcribed by RNA polymerase III (Pol III). Although previously thought to be expressed constitutively, Pol III-transcribed ncRNAs are expressed variably in healthy and disease states and play important roles therein, necessitating their profiling at the single-cell level. In this study, we developed a measurement protocol for nc886 as a model case and initial step for scRNA-seq for Pol III-transcribed ncRNAs. Specifically, we spiked in an oligo-tagged nc886-specific primer during the polyA tail capture process for the 5'scRNA-seq. We then produced sequencing libraries for standard 5' gene expression and oligo-tagged nc886 separately, to accommodate different cDNA sizes and ensure undisturbed transcriptome analysis. We applied this protocol in three cell lines that express high, low, and zero levels of nc886. Our results show that the identification of oligo tags exhibited limited target specificity, and sequencing reads of nc886 enabled the correction of non-specific priming. These findings suggest that gene-specific primers (GSPs) can be employed to capture RNAs lacking a polyA tail, with subsequent sequence verification ensuring accurate gene expression counting. Moreover, we embarked on an analysis of differentially expressed genes in cell line sub-clusters with differential nc886 expression, demonstrating variations in gene expression phenotypes. Collectively, the primer spike-in strategy allows combined analysis of ncRNAs and gene expression phenotype.


Sujet(s)
RNA polymerase III , ARN non traduit , Analyse de séquence d'ARN , Analyse sur cellule unique , Analyse sur cellule unique/méthodes , RNA polymerase III/génétique , RNA polymerase III/métabolisme , Humains , ARN non traduit/génétique , Analyse de séquence d'ARN/méthodes , Transcription génétique , Amorces ADN/génétique , Analyse de profil d'expression de gènes/méthodes
8.
J Endourol ; 2024 Sep 16.
Article de Anglais | MEDLINE | ID: mdl-39212680

RÉSUMÉ

Introduction: Testicular pain (TP) after laparoscopic donor nephrectomy (LDN) is a relatively underreported complication. This study aimed to investigate the incidence, characteristics, and factors associated with ipsilateral TP after left-sided LDN. Materials and Methods: This study prospectively collected baseline data and surgical details for all patients who underwent left-sided LDN during the study period. Each patient underwent scrotal ultrasonography 1 month postoperation. Donors were categorized by the level of gonadal vein ligation (level 1 at the renal vein confluence and level 2 at or below the iliac vessel crossing) and the presence or absence of TP. The characteristics of pain and demographics were compared across the groups. Results: Among 61 male patients who underwent left-sided LDN between March 2017 and December 2018, 54.1% (33/61) experienced ipsilateral TP. TP was more frequent in level 2 donors (64.3%) than in level 1 (45.5%), but the difference was not statistically significant (p = 0.141). Most TP occurred within a week (60.6%), was mild (75.8%), and resolved within 3 months (63.7%). The incidence of varicocele and hydrocele was 32.8% and 34.4%, respectively. The occurrence of TP was not significantly associated with the presence of varicocele or hydrocele and other factors. Conclusion: More than half of the male donors who underwent LDN experienced TP. The findings emphasize the importance of discussing this potential complication during preoperative counseling. This study found no significant association between TP and the level of gonadal vein ligation or the presence of varicocele, warranting further investigation into the cause of TP.

9.
J Med Virol ; 96(8): e29880, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-39185678

RÉSUMÉ

Human papillomavirus (HPV) is an important causative factor of cervical cancer and is associated with nonsmall cell lung cancer (NSCLC). Merkel cell polyomavirus (MCPyV) is a rare and highly fatal cutaneous virus that can cause Merkel cell carcinoma (MCC). Although coinfection with oncogenic HPV and MCPyV may increase cancer risk, a definitive etiological link has not been established. Recently, genomic variation and genetic diversity in the MCPyV noncoding control region (NCCR) among ethnic groups has been reported. The current study aimed to provide accurate prevalence information on HPV and MCPyV infection/coinfection in NSCLC patients and to evaluate and confirm Korean MCPyV NCCR variant genotypes and sequences. DNA from 150 NSCLC tissues and 150 adjacent control tissues was assessed via polymerase chain reaction (PCR) targeting regions of the large T antigen (LT-ag), viral capsid protein 1 (VP1), and NCCR. MCPyV was detected in 22.7% (34 of 150) of NSCLC tissues and 8.0% (12 of 150) of adjacent tissues from Korean patients. The incidence rates of HPV with and without MCPyV were 26.5% (nine of 34) and 12.9% (15 of 116). The MCPyV NCCR genotype prevalence in Korean patients was 21.3% (32 of 150) for subtype I and 6% (nine of 150) for subtype IIc. Subtype I, a predominant East Asian strain containing 25 bp tandem repeats, was most common in the MCPyV NCCR data set. Our results confirm that coinfection with other tumor-associated viruses is not associated with NSCLC. Although the role of NCCR rearrangements in MCPyV infection remains unknown, future studies are warranted to determine the associations of MCPyV NCCR sequence rearrangements with specific diseases.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Variation génétique , Génotype , Polyomavirus des cellules de Merkel , Infections à papillomavirus , Humains , Carcinome pulmonaire non à petites cellules/virologie , Carcinome pulmonaire non à petites cellules/génétique , Femelle , Polyomavirus des cellules de Merkel/génétique , Polyomavirus des cellules de Merkel/isolement et purification , Adulte d'âge moyen , Mâle , Sujet âgé , Infections à papillomavirus/virologie , Infections à papillomavirus/complications , Infections à papillomavirus/épidémiologie , République de Corée/épidémiologie , Infections à polyomavirus/virologie , Infections à polyomavirus/épidémiologie , Infections à polyomavirus/complications , Papillomaviridae/génétique , Papillomaviridae/classification , Adulte , Co-infection/virologie , Co-infection/épidémiologie , Tumeurs du poumon/virologie , Sujet âgé de 80 ans ou plus , Prévalence , ADN viral/génétique , Infections à virus oncogènes/virologie , Infections à virus oncogènes/complications , Infections à virus oncogènes/épidémiologie , Réaction de polymérisation en chaîne , Virus des Papillomavirus humains
10.
Mol Ther Nucleic Acids ; 35(3): 102270, 2024 Sep 10.
Article de Anglais | MEDLINE | ID: mdl-39171141

RÉSUMÉ

Recombinant adenovirus (rAdV) vector is the most promising vehicle to deliver an exogenous gene into target cells and is preferred for gene therapy. Exogenous gene expression from rAdV is often too inefficient to induce phenotypic changes and the amount of administered rAdV must be very high to achieve a therapeutic dose. However, it is often hampered because a high dose of rAdV is likely to induce cytotoxicity by activating immune responses. nc886, a 102-nucleotide non-coding RNA that is transcribed by RNA polymerase III, acts as an immune suppressor and a facilitator of AdV entry into the nucleus. Therefore, in this study, we have constructed an rAdV expressing nc886 (AdV:nc886) to explore whether AdV:nc886 overcomes the aforementioned drawbacks of conventional rAdV vectors. When infected into mouse cell lines and mice, AdV:nc886 expresses a sufficient amount of nc886, which suppresses the induction of interferon-stimulated genes and apoptotic pathways triggered by AdV infection. As a result, AdV:nc886 is less cytotoxic and produces more rAdV-delivered gene products, compared with the parental rAdV vector lacking nc886. In conclusion, this study demonstrates that the nc886-expressing rAdV could become a superior gene delivery vehicle with greater safety and higher efficiency for in vivo gene therapy.

11.
Immune Netw ; 24(3): e22, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38974212

RÉSUMÉ

[This corrects the article e22 in vol. 21, PMID: 34277112.].

12.
Curr Opin Microbiol ; 80: 102514, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-39024914

RÉSUMÉ

The sophisticated ability of living organisms to sense and respond to external stimuli is critical for survival. This is particularly true for fungal pathogens, where the capacity to adapt and proliferate within a host is essential. To this end, signaling pathways, whether evolutionarily conserved or unique, have been refined through interactions with the host. Cryptococcus neoformans, an opportunistic fungal pathogen, is responsible for over 190,000 cases and an estimated 147,000 annual deaths globally. Extensive research over the past decades has shed light on the signaling pathways underpinning the pathogenicity of C. neoformans, as well as the host's responses during infection. In this context, we delineate the regulatory mechanisms employed by C. neoformans to detect and react to stresses derived from the host.


Sujet(s)
Cryptococcus neoformans , Interactions hôte-pathogène , Transduction du signal , Stress physiologique , Cryptococcus neoformans/pathogénicité , Cryptococcus neoformans/physiologie , Cryptococcus neoformans/métabolisme , Cryptococcus neoformans/génétique , Humains , Animaux , Méningite cryptococcique/microbiologie , Régulation de l'expression des gènes fongiques , Protéines fongiques/métabolisme , Protéines fongiques/génétique
13.
Food Chem ; 459: 140333, 2024 Nov 30.
Article de Anglais | MEDLINE | ID: mdl-38996638

RÉSUMÉ

Colorants, especially synthetic colorants, play a crucial role in enhancing the aesthetic qualities of food owing to their cost-effectiveness and stability against environmental factors. Ensuring the safe and regulated use of colorants is essential for maintaining consumer trust in food safety. Various preparation and analytical technologies, which are continuously undergoing improvement, are currently used to quantify of synthetic colorants in food products. This paper reviews recent developments in analytical techniques for synthetic food colorants, detection and compares the operational principles, advantages, and disadvantages of each technology. Additionally, it also explores advancements in these technologies, discussing several invaluable tools of analysis, such as high-performance liquid chromatography, liquid chromatography-tandem mass spectrometry, electrochemical sensors, digital image analysis, near-infrared spectroscopy, and surface-enhanced Raman spectroscopy. This comprehensive overview aims to provide valuable insights into current progress and research in the field of food colorant analysis.


Sujet(s)
Colorants alimentaires , Colorants alimentaires/analyse , Colorants alimentaires/composition chimique , Analyse d'aliment/méthodes , Chromatographie en phase liquide à haute performance , Analyse spectrale Raman/méthodes , Spectrométrie de masse en tandem/méthodes
14.
Food Chem ; 456: 139872, 2024 Oct 30.
Article de Anglais | MEDLINE | ID: mdl-38865818

RÉSUMÉ

The release of hydrogen cyanide (HCN) after food ingestion can pose a serious health risk to consumers. This study aimed to simultaneously quantify four cyanogenic glycosides (lotaustralin, prunasin, taxiphyllin, and dhurrin) using liquid chromatography-tandem mass spectrometry. The analysis scope extended beyond agricultural products to various consumer foods to estimate dietary exposure to cyanogenic glycosides and assess its risk levels. The major exposure sources are cassava chips (lotaustralin), apples (seeds) (prunasin and dhurrin), and Prunus mume axis (taxiphyllin). In addition to quantifying specific cyanogenic glycosides, this study proposed the development of a preliminary risk assessment framework based on the dietary exposure assessment and the calculation of theoretical levels of HCN derived from cyanogenic glycoside concentrations. In the absence of established guidelines for the permissible intake of foods containing cyanogenic glycosides, this study provides initial guidance for assessing the risks associated with a range of commonly consumed foods.


Sujet(s)
Contamination des aliments , Hétérosides , Acide cyanhydrique , Manihot , Hétérosides/composition chimique , Hétérosides/analyse , Acide cyanhydrique/analyse , Acide cyanhydrique/composition chimique , Humains , Contamination des aliments/analyse , Manihot/composition chimique , République de Corée , Spectrométrie de masse en tandem , Malus/composition chimique , Adulte , Prunus/composition chimique , Exposition alimentaire/analyse , Appréciation des risques , Jeune adulte
15.
J Microbiol Biotechnol ; 34(7): 1365-1375, 2024 Jul 28.
Article de Anglais | MEDLINE | ID: mdl-38881183

RÉSUMÉ

The rise of Candida auris, a multidrug-resistant fungal pathogen, across more than 40 countries, has signaled an alarming threat to global health due to its significant resistance to existing antifungal therapies. Characterized by its rapid spread and robust drug resistance, C. auris presents a critical challenge in managing infections, particularly in healthcare settings. With research on its biological traits and genetic basis of virulence and resistance still in the early stages, there is a pressing need for a concerted effort to understand and counteract this pathogen. This review synthesizes current knowledge on the epidemiology, biology, genetic manipulation, pathogenicity, diagnostics, and resistance mechanisms of C. auris, and discusses future directions in research and therapeutic development. By exploring the complexities surrounding C. auris, we aim to underscore the importance of advancing research to devise effective control and treatment strategies.


Sujet(s)
Antifongiques , Candida auris , Candidose , Multirésistance des champignons aux médicaments , Humains , Antifongiques/pharmacologie , Antifongiques/usage thérapeutique , Multirésistance des champignons aux médicaments/génétique , Candidose/microbiologie , Candidose/traitement médicamenteux , Candida auris/génétique , Candida auris/effets des médicaments et des substances chimiques , Virulence , Animaux , Candida/effets des médicaments et des substances chimiques , Candida/génétique , Candida/pathogénicité
16.
World J Mens Health ; 2024 May 30.
Article de Anglais | MEDLINE | ID: mdl-38863376

RÉSUMÉ

PURPOSE: Physiological aging is associated with microvascular dysfunction, including in the penis, and this may contribute to age-related erectile dysfunction (ED). Low-intensity extracorporeal shockwave therapy (Li-ESWT) is a non-invasive intervention for ED, but its effect on penile microvascular function, remains unclear. Our objectives are to (i) evaluate the effect of Li-ESWT (specifically radial type ESWT [rESWT]) on penile microvascular perfusion (PMP) in aging rats, (ii) elucidate a possible mechanism, and (iii) evaluate its impact on angiogenic and smooth muscle biomarkers in cavernosal tissue. MATERIALS AND METHODS: Male rats (n=9; 15-18 months) were anesthetized and subjected to rESWT while monitoring PMP. The nitric oxide (NO) pathway involvement was assessed by measuring the effect of rESWT on PMP following an intracavernosal injection of N(G)-nitroarginine methyl ester (L-NAME) (NO synthase inhibitor). To elucidate the cellular mechanism, another group of rats received repeated rESWT (n=4) or no treatment (n=4) three times/week for two weeks. Rats were euthanized at the end of the study and penile tissues were analyzed for angiogenic markers (vascular endothelial growth factor-A [VEGF-A], endothelial nitric oxide synthase [eNOS]) and smooth muscle content (α-actin) using immunostaining, Western blot, and quantitative polymerase chain reaction (qPCR). RESULTS: rESWT resulted in more than a 2-fold increase in PMP (from 68.5 arbitrary units; 163.7 AU). L-NAME injection produced a <40%-50% decrease (185.3 to 101.0 AU) in rESWT-induced PMP response. Immunostaining revealed increased α-actin, eNOS, and VEGF-A in the cavernosum and these findings were confirmed by qPCR and Western blot results. CONCLUSIONS: rESWT improved PMP, which may be mediated via increased VEGF expression, which stimulates the NO/cyclic guanosine monophosphate pathway, resulting in sustained PMP. rESWT devices could offer a safe, non-invasive treatment for age-related ED.

17.
mBio ; 15(7): e0115624, 2024 Jul 17.
Article de Anglais | MEDLINE | ID: mdl-38874410

RÉSUMÉ

Mitogen-activated protein kinase (MAPK) pathways are fundamental to the regulation of biological processes in eukaryotic organisms. The basidiomycete Cryptococcus neoformans, known for causing fungal meningitis worldwide, possesses five MAPKs. Among these, Cpk1, Hog1, and Mpk1 have established roles in sexual reproduction, stress responses, and cell wall integrity. However, the roles of Cpk2 and Mpk2 are less understood. Our study elucidates the functional interplay between the Cpk1/Cpk2 and Mpk1/Mpk2 MAPK pathways in C. neoformans. We discovered that CPK2 overexpression compensates for cpk1Δ mating deficiencies via the Mat2 transcription factor, revealing functional redundancy between Cpk1 and Cpk2. We also found that Mpk2 is phosphorylated in response to cell wall stress, a process regulated by the MAPK kinase (MAP2K) Mkk2 and MAP2K kinases (MAP3Ks) Ssk2 and Ste11. Overexpression of MPK2 partially restores cell wall integrity in mpk1Δ by influencing key cell wall components, such as chitin and the polysaccharide capsule. Contrarily, MPK2 overexpression cannot restore thermotolerance and cell membrane integrity in mpk1Δ. These results suggest that Mpk1 and Mpk2 have redundant and opposing roles in the cellular response to cell wall and membrane stresses. Most notably, the dual deletion of MPK1 and MPK2 restores wild-type mating efficiency in cpk1Δ mutants via upregulation of the mating-regulating transcription factors MAT2 and ZNF2, suggesting that the Mpk1 and Mpk2 cooperate to negatively regulate the pheromone-responsive Cpk1 MAPK pathway. Our research collectively underscores a sophisticated regulatory network of cryptococcal MAPK signaling pathways that intricately govern sexual reproduction and cell wall integrity, thereby controlling fungal development and pathogenicity.IMPORTANCEIn the realm of fungal biology, our study on Cryptococcus neoformans offers pivotal insights into the roles of specific proteins called mitogen-activated protein kinases (MAPKs). Here, we discovered the cryptic functions of Cpk2 and Mpk2, two MAPKs previously overshadowed by their dominant counterparts Cpk1 and Mpk1, respectively. Our findings reveal that these "underdog" proteins are not just backup players; they play crucial roles in vital processes like mating and cell wall maintenance in C. neoformans. Their ability to step in and compensate when their dominant counterparts are absent showcases the adaptability of C. neoformans. This newfound understanding not only enriches our knowledge of fungal MAPK mechanisms but also underscores the intricate balance and interplay of proteins in ensuring the organism's survival and adaptability.


Sujet(s)
Paroi cellulaire , Cryptococcus neoformans , Mitogen-Activated Protein Kinases , Cryptococcus neoformans/génétique , Cryptococcus neoformans/enzymologie , Mitogen-Activated Protein Kinases/génétique , Mitogen-Activated Protein Kinases/métabolisme , Paroi cellulaire/métabolisme , Paroi cellulaire/génétique , Régulation de l'expression des gènes fongiques , Protéines fongiques/génétique , Protéines fongiques/métabolisme , Phosphorylation , Système de signalisation des MAP kinases
18.
Korean J Radiol ; 25(6): 565-574, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38807338

RÉSUMÉ

OBJECTIVE: To evaluate the safety and clinical outcomes of the Passeo-18 Lux drug-coated balloon (DCB) in endovascular revascularization procedures under real-world conditions in a Korean population with atherosclerotic disease of the infrainguinal arteries, including below-the-knee (BTK) arteries. MATERIALS AND METHODS: Eight institutions in the Republic of Korea participated in this prospective, multicenter, single-arm, post-market surveillance study. Two hundred patients with Rutherford class 2-5 peripheral arterial disease and infrainguinal lesions suitable for endovascular treatment were competitively enrolled. Data were collected at baseline, the time of intervention, discharge, and 1-, 6-, 12-, and 24-month follow-up visits. The primary safety endpoint was freedom from major adverse events (MAE) within 6 months (except when limiting the time frame for procedure- or device-related mortality to within 30 days), and the primary effectiveness endpoint was freedom from clinically driven target lesion revascularization (CD-TLR) within 12 months after the procedure. RESULTS: A total of 197 patients with 332 target lesions were analyzed. Two-thirds of the patients had diabetes mellitus, and 41.6% had chronic limb-threatening ischemia. The median target lesion length was 100 mm (interquartile range: 56-133 mm). Of the target lesions, 35.2% were occlusions, and 14.8% were located in the BTK arteries. Rate of freedom from MAE was 97.9% at 6 months, and the rate of freedom from CD-TLR was 95.0% and 92.2% at 12 and 24 months, respectively. Subgroup analysis of 43 patients and 49 target lesions involving the BTK arteries showed rate of freedom from MAE of 92.8% at 6 months and rates of freedom from CD-TLR of 88.8% and 84.4% at 12 and 24 months, respectively. CONCLUSION: The results of the present study, including the BTK subgroup analysis, showed outcomes comparable to those of other DCB studies, confirming the safety and effectiveness of Passeo-18 Lux DCB in the Korean population.


Sujet(s)
Angioplastie par ballonnet , Maladie artérielle périphérique , Surveillance post-commercialisation des produits de santé , Humains , Mâle , Femelle , Sujet âgé , Études prospectives , Maladie artérielle périphérique/imagerie diagnostique , Maladie artérielle périphérique/chirurgie , Maladie artérielle périphérique/thérapie , République de Corée , Angioplastie par ballonnet/méthodes , Adulte d'âge moyen , Résultat thérapeutique , Matériaux revêtus, biocompatibles , Procédures endovasculaires/méthodes , Sujet âgé de 80 ans ou plus
19.
Int J Mol Sci ; 25(10)2024 May 19.
Article de Anglais | MEDLINE | ID: mdl-38791588

RÉSUMÉ

Several clinical studies reported that the elevated expression of Chitinase-3-like 1 (CHI3L1) was observed in patients suffering from a wide range of diseases: cancer, metabolic, and neurological diseases. However, the role of CHI3L1 in AD is still unclear. Our previous study demonstrated that 2-({3-[2-(1-Cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2-quinazolinyl}culfanyl)-N-(4-ethylphenyl)butanamide, a CHI3L1 inhibiting compound, alleviates memory and cognitive impairment and inhibits neuroinflammation in AD mouse models. In this study, we studied the detailed correlation of CHI3L1 and AD using serum from AD patients and using CHI3L1 knockout (KO) mice with Aß infusion (300 pmol/day, 14 days). Serum levels of CHI3L1 were significantly elevated in patients with AD compared to normal subjects, and receiver operating characteristic (ROC) analysis data based on serum analysis suggested that CHI3L1 could be a significant diagnostic reference for AD. To reveal the role of CHI3L1 in AD, we investigated the CHI3L1 deficiency effect on memory impairment in Aß-infused mice and microglial BV-2 cells. In CHI3L1 KO mice, Aß infusion resulted in lower levels of memory dysfunction and neuroinflammation compared to that of WT mice. CHI3L1 deficiency selectively inhibited phosphorylation of ERK and IκB as well as inhibition of neuroinflammation-related factors in vivo and in vitro. On the other hand, treatment with recombinant CHI3L1 increased neuroinflammation-related factors and promoted phosphorylation of IκB except for ERK in vitro. Web-based gene network analysis and our results showed that CHI3L1 is closely correlated with PTX3. Moreover, in AD patients, we found that serum levels of PTX3 were correlated with serum levels of CHI3L1 by Spearman correlation analysis. These results suggest that CHI3L1 deficiency could inhibit AD development by blocking the ERK-dependent PTX3 pathway.


Sujet(s)
Maladie d'Alzheimer , Protéine-1 similaire à la chitinase-3 , Humains , Souris , Quinazolines/administration et posologie , Modèles animaux de maladie humaine , Maladie d'Alzheimer/sang , Maladie d'Alzheimer/métabolisme , Maladie d'Alzheimer/anatomopathologie , Peptides bêta-amyloïdes/métabolisme , Encéphale/métabolisme , Encéphale/anatomopathologie , Maladies neuro-inflammatoires/métabolisme , Maladies neuro-inflammatoires/anatomopathologie , Microglie/métabolisme , Microglie/anatomopathologie , Composant sérique amyloïde P/métabolisme , Protéine C-réactive/métabolisme , Protéine-1 similaire à la chitinase-3/sang , Protéine-1 similaire à la chitinase-3/génétique , Marqueurs biologiques/sang
20.
Br J Pharmacol ; 181(17): 3232-3245, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-38745399

RÉSUMÉ

BACKGROUND AND PURPOSE: Chitinase-3-like 1 (CHI3L1) causes skin inflammation in the progression of atopic dermatitis. We investigated if anti-CHI3L1 antibody could prevent the development of atopic dermatitis and its mechanisms of action. EXPERIMENTAL APPROACH: The effect of CHI3L1 antibody on phthalic anhydride-induced atopic dermatitis animal model and in vitro reconstructed human skin (RHS) model were investigated. Expression and release of atopic dermatitis-related cytokines were determined using an enzyme-linked immunosorbent assay, and RT-qPCR, STAT3 and CXCL8 signalling were measured by western blotting. KEY RESULTS: Anti-CHI3L1 antibody suppressed phthalic anhydride-induced epidermal thickening, clinical score, IgE level and infiltration of inflammatory cells, and reduced phthalic anhydride-induced inflammatory cytokines concentration. In addition, CHI3L1 antibody treatment inhibited the expression of STAT3 activity in phthalic anhydride-treated skin. It was also confirmed that CHI3L1 antibody treatment alleviated atopic dermatitis-related inflammation in the RHS model. The inhibitory effects of CHI3L1 antibody was similar or more effective compared with that of the IL-4 antibody. We further found that CHI3L1 is associated with CXCL8 by protein-association network analysis. siRNA of CHI3L1 blocked the mRNA levels of CHI3L1, IL-1ß, IL-4, CXCL8, TSLP, and the expression of CHI3L1 and p-STAT, and the level of CXCL8, whereas recombinant level of CXCL8 was elevated. Moreover, siRNA of STAT3 reduced the mRNA level of these cytokines. CHI3L1 and p-STAT3 expression correlated with the reduced CXCL8 level in the RHS in vitro model. CONCLUSION AND IMPLICATIONS: Our data demonstrated that CHI3L1 antibody could be a promising effective therapeutic drug for atopic dermatitis.


Sujet(s)
Protéine-1 similaire à la chitinase-3 , Eczéma atopique , Interleukine-8 , Facteur de transcription STAT-3 , Eczéma atopique/traitement médicamenteux , Eczéma atopique/immunologie , Eczéma atopique/métabolisme , Eczéma atopique/anatomopathologie , Facteur de transcription STAT-3/métabolisme , Facteur de transcription STAT-3/antagonistes et inhibiteurs , Humains , Animaux , Interleukine-8/métabolisme , Protéine-1 similaire à la chitinase-3/antagonistes et inhibiteurs , Protéine-1 similaire à la chitinase-3/métabolisme , Peau/effets des médicaments et des substances chimiques , Peau/anatomopathologie , Peau/métabolisme , Mâle , Souris de lignée BALB C , Anhydrides phtaliques/pharmacologie , Anticorps/pharmacologie , Souris , Femelle , Inflammation/traitement médicamenteux , Inflammation/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE